Literature DB >> 28124177

TFG associated hereditary spastic paraplegia: an addition to the phenotypic spectrum.

Huma Tariq1, Sadaf Naz2.   

Abstract

Hereditary spastic paraplegias (HSPs) constitute movement disorders with extreme lower limb spasticity caused by axonopathies of the upper motor neurons. We describe two siblings affected with a recessive form of movement disorder. Whole-exome sequencing revealed a homozygous missense mutation c.64 C>T (p.Arg22Trp) in TFG as cause of the disorder. Comparison of the phenotype of the patients of this study, with that reported previously, revealed differences in the severity of the disorder as well as new clinical findings. These include presence of clonus, undeveloped speech, and sleep disturbances. Our findings extend the phenotypic spectrum associated with the TFG mutations in HSP.

Entities:  

Keywords:  Pakistan; Reverse phenotyping; SPG57; Spastic paraplegia; TFG

Mesh:

Substances:

Year:  2017        PMID: 28124177     DOI: 10.1007/s10048-017-0508-6

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  20 in total

Review 1.  Genetics of movement disorders and ataxia.

Authors:  Paul R Jarman; Nicholas W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  HMSN-P caused by p.Pro285Leu mutation in TFG is not confined to patients with Far East ancestry.

Authors:  Afagh Alavi; Hosein Shamshiri; Shahriar Nafissi; Marzieh Khani; Brandy Klotzle; Jian-Bing Fan; Frank Steemers; Elahe Elahi
Journal:  Neurobiol Aging       Date:  2014-12-16       Impact factor: 4.673

Review 3.  Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias.

Authors:  Cynthia Soderblom; Craig Blackstone
Journal:  Pharmacol Ther       Date:  2005-07-07       Impact factor: 12.310

4.  Autozygosity mapping with exome sequence data.

Authors:  Ian M Carr; Sanjeev Bhaskar; James O'Sullivan; Mohammed A Aldahmesh; Hanan E Shamseldin; Alexander F Markham; David T Bonthron; Graeme Black; Fowzan S Alkuraya
Journal:  Hum Mutat       Date:  2012-10-22       Impact factor: 4.878

5.  Novel Genetic, Clinical, and Pathomechanistic Insights into TFG-Associated Hereditary Spastic Paraplegia.

Authors:  Gaurav V Harlalka; Meriel E McEntagart; Neerja Gupta; Anna E Skrzypiec; Mariusz W Mucha; Barry A Chioza; Michael A Simpson; Ajith Sreekantan-Nair; Anthony Pereira; Sven Günther; Amir Jahic; Hamid Modarres; Heather Moore-Barton; Richard C Trembath; Madhulika Kabra; Emma L Baple; Seema Thakur; Michael A Patton; Christian Beetz; Robert Pawlak; Andrew H Crosby
Journal:  Hum Mutat       Date:  2016-08-30       Impact factor: 4.878

Review 6.  Cellular pathways of hereditary spastic paraplegia.

Authors:  Craig Blackstone
Journal:  Annu Rev Neurosci       Date:  2012-04-20       Impact factor: 12.449

Review 7.  Spastic movement disorder.

Authors:  V Dietz
Journal:  Spinal Cord       Date:  2000-07       Impact factor: 2.772

8.  Overexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome.

Authors:  Uirá S Melo; Lucia I Macedo-Souza; Thalita Figueiredo; Alysson R Muotri; Joseph G Gleeson; Gabriela Coux; Pablo Armas; Nora B Calcaterra; João P Kitajima; Simone Amorim; Thiago R Olávio; Karina Griesi-Oliveira; Giuliana C Coatti; Clarissa R R Rocha; Marinalva Martins-Pinheiro; Carlos F M Menck; Maha S Zaki; Fernando Kok; Mayana Zatz; Silvana Santos
Journal:  Hum Mol Genet       Date:  2015-09-18       Impact factor: 6.150

9.  A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function.

Authors:  Pei-Chien Tsai; Yen-Hua Huang; Yuh-Cherng Guo; Hung-Ta Wu; Kon-Ping Lin; Yu-Shuen Tsai; Yi-Chu Liao; Yo-Tsen Liu; Tze-Tze Liu; Lung-Sen Kao; Shaw-Fang Yet; Ming-Ji Fann; Bing-Wen Soong; Yi-Chung Lee
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

10.  Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure.

Authors:  Christian Beetz; Adam Johnson; Amber L Schuh; Seema Thakur; Rita-Eva Varga; Thomas Fothergill; Nicole Hertel; Ewa Bomba-Warczak; Holger Thiele; Gudrun Nürnberg; Janine Altmüller; Renu Saxena; Edwin R Chapman; Erik W Dent; Peter Nürnberg; Anjon Audhya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more
  5 in total

1.  R106C TFG variant causes infantile neuroaxonal dystrophy "plus" syndrome.

Authors:  A Catania; R Battini; T Pippucci; R Pasquariello; M L Chiapparini; M Seri; B Garavaglia; G Zorzi; N Nardocci; D Ghezzi; V Tiranti
Journal:  Neurogenetics       Date:  2018-07-03       Impact factor: 2.660

2.  A novel homozygous mutation of the TFG gene in a patient with early onset spastic paraplegia and later onset sensorimotor polyneuropathy.

Authors:  Takuya Miyabayashi; Tatsuhiro Ochiai; Naoki Suzuki; Masashi Aoki; Takehiko Inui; Yukimune Okubo; Ryo Sato; Noriko Togashi; Hiroshi Takashima; Hiroyuki Ishiura; Shoji Tsuji; Kishin Koh; Yoshihisa Takiyama; Kazuhiro Haginoya
Journal:  J Hum Genet       Date:  2018-11-22       Impact factor: 3.172

3.  TFG regulates secretory and endosomal sorting pathways in neurons to promote their activity and maintenance.

Authors:  Jennifer L Peotter; Iryna Pustova; Molly M Lettman; Shalini Shatadal; Mazdak M Bradberry; Allison D Winter-Reed; Maya Charan; Erin E Sharkey; James R Alvin; Alyssa M Bren; Annika K Oie; Edwin R Chapman; M Shahriar Salamat; Anjon Audhya
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

4.  A novel TFG c.793C>G mutation in a Chinese pedigree with Charcot-Marie-Tooth disease 2.

Authors:  Ding-Wen Wu; Yanfang Li; Xinzhen Yin; Baorong Zhang
Journal:  Brain Behav       Date:  2020-07-14       Impact factor: 2.708

5.  Trk-fused gene (TFG) regulates pancreatic β cell mass and insulin secretory activity.

Authors:  Takeshi Yamamotoya; Yusuke Nakatsu; Akifumi Kushiyama; Yasuka Matsunaga; Koji Ueda; Yuki Inoue; Masa-Ki Inoue; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Hiroshi Kiyonari; Hisamitsu Ishihara; Tomoichiro Asano
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.